Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B
- PMID: 8392630
- PMCID: PMC237899
- DOI: 10.1128/JVI.67.8.5068-5074.1993
Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B
Abstract
A recombinant Epstein-Barr virus (EBV) was constructed, with a positive-selection marker inserted at the site of a deletion of a DNA segment which encodes the first five transmembrane domains of LMP2A and LMP2B. Despite the mutation, the mutant recombinant EBV was able to initiate and maintain primary B-lymphocyte growth transformation in vitro. Cells transformed with the mutant recombinant were not different from wild-type virus transformants in initial or long-term outgrowth, sensitivity to limiting cell dilution, or serum requirement. Expression of EBNA1, EBNA2, EBNA3A, EBNA3C, and LMP1 and permissivity for lytic EBV infection were also unaffected by the LMP2 deletion mutation. These results complete the molecular genetic studies proving LMP2 is dispensable for primary B-lymphocyte growth transformation, latent infection, and lytic virus replication in vitro.
Similar articles
-
The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.J Virol. 1992 Nov;66(11):6461-9. doi: 10.1128/JVI.66.11.6461-6469.1992. J Virol. 1992. PMID: 1328675 Free PMC article.
-
The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.J Virol. 1993 Apr;67(4):2006-13. doi: 10.1128/JVI.67.4.2006-2013.1993. J Virol. 1993. PMID: 8383224 Free PMC article.
-
An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.J Virol. 1994 Mar;68(3):1449-58. doi: 10.1128/JVI.68.3.1449-1458.1994. J Virol. 1994. PMID: 8107208 Free PMC article.
-
EBNA2 and Its Coactivator EBNA-LP.Curr Top Microbiol Immunol. 2015;391:35-59. doi: 10.1007/978-3-319-22834-1_2. Curr Top Microbiol Immunol. 2015. PMID: 26428371 Review.
-
Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2.Leukemia. 1994 Apr;8 Suppl 1:S46-50. Leukemia. 1994. PMID: 8152303 Review.
Cited by
-
Strong selective pressure for evolution of an Epstein-Barr virus LMP2B homologue in the rhesus lymphocryptovirus.J Virol. 1999 Oct;73(10):8867-72. doi: 10.1128/JVI.73.10.8867-8872.1999. J Virol. 1999. PMID: 10482645 Free PMC article.
-
Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.J Virol. 1997 Apr;71(4):2765-71. doi: 10.1128/JVI.71.4.2765-2771.1997. J Virol. 1997. PMID: 9060630 Free PMC article.
-
Role of Epstein-Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma.Cancers (Basel). 2021 Feb 1;13(3):561. doi: 10.3390/cancers13030561. Cancers (Basel). 2021. PMID: 33535665 Free PMC article.
-
EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.J Virol. 2004 Apr;78(8):3919-29. doi: 10.1128/jvi.78.8.3919-3929.2004. J Virol. 2004. PMID: 15047808 Free PMC article.
-
Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture.J Virol. 1993 Dec;67(12):7634-40. doi: 10.1128/JVI.67.12.7634-7640.1993. J Virol. 1993. PMID: 8230482 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources